Hepatocellular carcinoma: molecular mechanisms and targeted therapies

A Alqahtani, Z Khan, A Alloghbi, T S. Said Ahmed… - Medicina, 2019 - mdpi.com
Hepatocellular carcinoma (HCC) is one of the most common and lethal malignant tumors
worldwide. HCC is a complex process that is associated with several etiological factors …

The biology of Hepatocellular carcinoma: implications for genomic and immune therapies

G Khemlina, S Ikeda, R Kurzrock - Molecular cancer, 2017 - Springer
Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is a leading
cause of cancer-related death worldwide. It is highly refractory to most systemic therapies …

Comprehensive characterization of molecular differences in cancer between male and female patients

Y Yuan, L Liu, H Chen, Y Wang, Y Xu, H Mao, J Li… - Cancer cell, 2016 - cell.com
An individual's sex has been long recognized as a key factor affecting cancer incidence,
prognosis, and treatment responses. However, the molecular basis for sex disparities in …

Landscape of phosphatidylinositol-3-kinase pathway alterations across 19 784 diverse solid tumors

SZ Millis, S Ikeda, S Reddy, Z Gatalica… - JAMA oncology, 2016 - jamanetwork.com
Importance Molecular aberrations in the phosphatidylinositol-3-kinase (PI3K) pathway drive
tumorigenesis. Frequently co-occurring alterations in hormone receptors and/or human …

The crucial role of multiomic approach in cancer research and clinically relevant outcomes

M Lu, X Zhan - EPMA Journal, 2018 - Springer
Cancer with heavily economic and social burden is the hot point in the field of medical
research. Some remarkable achievements have been made; however, the exact …

[HTML][HTML] Genetic alterations in hepatocellular carcinoma: An update

ZS Niu, XJ Niu, WH Wang - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths
worldwide. Although recent advances in therapeutic approaches for treating HCC have …

Molecular pathogenesis of nonalcoholic steatohepatitis‐(NASH‐) related hepatocellular carcinoma

O Kutlu, HN Kaleli, E Ozer - Canadian Journal of …, 2018 - Wiley Online Library
The proportion of obese or diabetic population has been anticipated to increase in the
upcoming decades, which rises the prevalence of nonalcoholic fatty liver disease (NAFLD) …

Hepatocellular carcinoma in non-alcoholic fatty liver disease: from epidemiology to diagnostic approach

I Grgurevic, T Bozin, M Mikus, M Kukla, J O'Beirne - Cancers, 2021 - mdpi.com
Simple Summary Non-alcoholic fatty liver disease (NAFLD) is expected to become the
leading cause of hepatocellular carcinoma (HCC) in the near future. In this article, we review …

[HTML][HTML] Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma

S Talamantes, M Lisjak, EH Gilglioni… - JHEP Reports, 2023 - Elsevier
Obesity-related complications such as non-alcoholic fatty liver disease (NAFLD) and type 2
diabetes (T2D) are well-established risk factors for the development of hepatocellular …

TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication

DWH Ho, LK Chan, YT Chiu, IMJ Xu, RTP Poon… - Gut, 2017 - gut.bmj.com
Objective We investigated the mutational landscape of mammalian target of rapamycin
(mTOR) signalling cascade in hepatocellular carcinomas (HCCs) with chronic HBV …